• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 B 中的阿什肯纳兹突变导致家族性高胆固醇血症的临床特征。

Clinical characterization of familial hypercholesterolemia due to an amish founder mutation in Apolipoprotein B.

机构信息

Clinic for Special Children, Strasburg, PA, USA.

Center for Special Children - La Farge Medical Clinic - Vernon Memorial Healthcare, La Farge, WI, USA.

出版信息

BMC Cardiovasc Disord. 2022 Mar 17;22(1):109. doi: 10.1186/s12872-022-02539-3.

DOI:10.1186/s12872-022-02539-3
PMID:35300601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8928591/
Abstract

BACKGROUND

Familial hypercholesterolemia (FH) due to a founder variant in Apolipoprotein B (ApoB) is reported in 12% of the Pennsylvania Amish community. By studying a cohort of ApoB heterozygotes and homozygotes, we aimed to characterize the biochemical and cardiac imaging features in children and young adults with a common genetic background and similar lifestyle.

METHODS

We employed advanced lipid profile testing, carotid intima media thickness (CIMT), pulse wave velocity (PWV), and peripheral artery tonometry (PAT) to assess atherosclerosis in a cohort of Amish ApoB heterozygotes (n = 13), homozygotes (n = 3), and their unaffected, age-matched siblings (n = 9). ApoB homozygotes were not included in statistical comparisons.

RESULTS

LDL cholesterol (LDL-C) was significantly elevated among ApoB heterozygotes compared to sibling controls, though several ApoB heterozygotes had LDL-C levels in the normal range. LDL particles (LDL-P), small, dense LDL particles, and ApoB were also significantly elevated among subjects with ApoB. Despite these differences in serum lipids and particles, CIMT and PWV were not significantly different between ApoB heterozygotes and controls in age-adjusted analysis.

CONCLUSIONS

We provide a detailed description of the serum lipids, atherosclerotic plaque burden, vascular stiffness, and endothelial function among children and young adults with FH due to heterozygous ApoB. Fasting LDL-C was lower than what is seen with other forms of FH, and even normal in several ApoB heterozygotes, emphasizing the importance of cascade genetic testing among related individuals for diagnosis. We found increased number of LDL particles among ApoB heterozygotes but an absence of detectable atherosclerosis.

摘要

背景

在宾夕法尼亚州的阿米什社区,12%的家族性高胆固醇血症(FH)归因于载脂蛋白 B(ApoB)的创始人变体。通过研究载脂蛋白 B 杂合子和纯合子的队列,我们旨在描述具有共同遗传背景和相似生活方式的儿童和年轻成人的生化和心脏成像特征。

方法

我们采用先进的血脂谱检测、颈动脉内膜中层厚度(CIMT)、脉搏波速度(PWV)和外周动脉张力计(PAT)评估一组阿米什载脂蛋白 B 杂合子(n=13)、纯合子(n=3)及其无影响、年龄匹配的兄弟姐妹(n=9)的动脉粥样硬化情况。载脂蛋白 B 纯合子不包括在统计比较中。

结果

与兄弟姐妹对照组相比,载脂蛋白 B 杂合子的 LDL 胆固醇(LDL-C)显著升高,尽管一些载脂蛋白 B 杂合子的 LDL-C 水平在正常范围内。载脂蛋白 B 患者的 LDL 颗粒(LDL-P)、小而密的 LDL 颗粒和载脂蛋白 B 也明显升高。尽管血清脂质和颗粒存在这些差异,但在年龄调整分析中,载脂蛋白 B 杂合子与对照组之间的 CIMT 和 PWV 无显著差异。

结论

我们详细描述了杂合子载脂蛋白 B 导致的 FH 儿童和年轻成人的血清脂质、动脉粥样硬化斑块负担、血管僵硬和内皮功能。空腹 LDL-C 低于其他形式的 FH,甚至在几个载脂蛋白 B 杂合子中也正常,强调了对相关个体进行级联基因检测以进行诊断的重要性。我们发现载脂蛋白 B 杂合子中的 LDL 颗粒数量增加,但未检测到可察觉的动脉粥样硬化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec5/8928591/745a32aad58f/12872_2022_2539_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec5/8928591/8765e35fe398/12872_2022_2539_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec5/8928591/49ffc5bf7a45/12872_2022_2539_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec5/8928591/745a32aad58f/12872_2022_2539_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec5/8928591/8765e35fe398/12872_2022_2539_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec5/8928591/49ffc5bf7a45/12872_2022_2539_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec5/8928591/745a32aad58f/12872_2022_2539_Fig3_HTML.jpg

相似文献

1
Clinical characterization of familial hypercholesterolemia due to an amish founder mutation in Apolipoprotein B.载脂蛋白 B 中的阿什肯纳兹突变导致家族性高胆固醇血症的临床特征。
BMC Cardiovasc Disord. 2022 Mar 17;22(1):109. doi: 10.1186/s12872-022-02539-3.
2
Evaluation of clinical diagnosis criteria of familial ligand defective apoB 100 and lipoprotein phenotype comparison between LDL receptor gene mutations affecting ligand-binding domain and the R3500Q mutation of the apoB gene in patients from a South European population.对来自南欧人群的患者中家族性配体缺陷载脂蛋白B 100的临床诊断标准进行评估,并比较影响配体结合域的低密度脂蛋白受体基因突变与载脂蛋白B基因的R3500Q突变之间的脂蛋白表型。
Transl Res. 2008 Mar;151(3):162-7. doi: 10.1016/j.trsl.2007.12.001. Epub 2008 Jan 7.
3
Differences in the phenotype between children with familial defective apolipoprotein B-100 and familial hypercholesterolemia.家族性载脂蛋白B-100缺陷儿童与家族性高胆固醇血症儿童之间的表型差异。
Arterioscler Thromb Vasc Biol. 1997 May;17(5):826-33. doi: 10.1161/01.atv.17.5.826.
4
The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.丹麦家族性高胆固醇血症的分子遗传基础与诊断
Dan Med Bull. 2002 Nov;49(4):318-45.
5
VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.由于低密度脂蛋白受体功能受损或载脂蛋白B-100缺陷导致的家族性高胆固醇血症中极低密度脂蛋白和中间密度脂蛋白载脂蛋白B-100的动力学
J Lipid Res. 1998 Feb;39(2):380-7.
6
Lipid and lipoprotein parameters for detection of familial hypercholesterolemia in childhood. The DECOPIN Project.用于检测儿童家族性高胆固醇血症的脂质和脂蛋白参数。DECOPIN项目。
Clin Investig Arterioscler. 2018 Jul-Aug;30(4):170-178. doi: 10.1016/j.arteri.2017.12.003. Epub 2018 Mar 27.
7
Decreased bone mineral density in subjects carrying familial defective apolipoprotein B-100.携带家族性载脂蛋白 B-100 缺陷的受试者骨密度降低。
J Clin Endocrinol Metab. 2013 Dec;98(12):E1999-2005. doi: 10.1210/jc.2013-2471. Epub 2013 Oct 8.
8
Familial Hyperlipidemia Caused by Apolipoprotein B Mutation in the Pediatric Amish Population: A Mini Review.儿科阿米什人群中载脂蛋白B突变引起的家族性高脂血症:一篇综述
Interv Cardiol (Lond). 2023;15(Suppl 17):433-437. Epub 2023 Jul 4.
9
Familial defective apolipoprotein B-100 and increased low-density lipoprotein cholesterol and coronary artery calcification in the old order amish.阿米什旧秩序群体中的家族性载脂蛋白B-100缺陷与低密度脂蛋白胆固醇升高及冠状动脉钙化
Arch Intern Med. 2010 Nov 8;170(20):1850-5. doi: 10.1001/archinternmed.2010.384.
10
Familial defective apolipoprotein B-100: A review.家族性载脂蛋白B-100缺陷:综述
J Clin Lipidol. 2016 Nov-Dec;10(6):1297-1302. doi: 10.1016/j.jacl.2016.09.009. Epub 2016 Sep 22.

引用本文的文献

1
Genetic Spectrum of Lithuanian Familial Hypercholesterolemia Patients.立陶宛家族性高胆固醇血症患者的基因谱
J Cardiovasc Dev Dis. 2025 May 21;12(5):197. doi: 10.3390/jcdd12050197.
2
Familial Hyperlipidemia Caused by Apolipoprotein B Mutation in the Pediatric Amish Population: A Mini Review.儿科阿米什人群中载脂蛋白B突变引起的家族性高脂血症:一篇综述
Interv Cardiol (Lond). 2023;15(Suppl 17):433-437. Epub 2023 Jul 4.
3
The Potential Therapeutic Application of Simvastatin for Brain Complications and Mechanisms of Action.辛伐他汀对脑部并发症的潜在治疗应用及作用机制

本文引用的文献

1
20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia.20 年随访家族性高胆固醇血症患儿他汀类药物治疗。
N Engl J Med. 2019 Oct 17;381(16):1547-1556. doi: 10.1056/NEJMoa1816454.
2
Genomic diagnostics within a medically underserved population: efficacy and implications.医疗资源匮乏人群中的基因组诊断:疗效和意义。
Genet Med. 2018 Jan;20(1):31-41. doi: 10.1038/gim.2017.76. Epub 2017 Jul 20.
3
Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.脂蛋白(a)作为心血管疾病的一个病因:来自流行病学、遗传学和生物学的见解
Pharmaceuticals (Basel). 2023 Jun 22;16(7):914. doi: 10.3390/ph16070914.
4
Genetic Testing for Familial Hypercholesterolemia in Clinical Practice.临床实践中的家族性高胆固醇血症基因检测。
Curr Atheroscler Rep. 2023 May;25(5):197-208. doi: 10.1007/s11883-023-01094-2. Epub 2023 Apr 15.
J Lipid Res. 2016 Nov;57(11):1953-1975. doi: 10.1194/jlr.R071233. Epub 2016 Sep 27.
4
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.儿童和青少年家族性高胆固醇血症:通过优化检测与治疗延长数十年寿命
Eur Heart J. 2015 Sep 21;36(36):2425-37. doi: 10.1093/eurheartj/ehv157. Epub 2015 May 25.
5
Early initiation of statin treatment in children with familial hypercholesterolaemia.家族性高胆固醇血症患儿他汀类药物治疗的早期启动
Curr Opin Lipidol. 2015 Jun;26(3):236-9. doi: 10.1097/MOL.0000000000000177.
6
Application of Pediatric and Adult Guidelines for Treatment of Lipid Levels Among US Adolescents Transitioning to Young Adulthood.美国青少年向成年过渡期血脂水平治疗的儿科和成人指南应用。
JAMA Pediatr. 2015 Jun;169(6):569-74. doi: 10.1001/jamapediatrics.2015.0168.
7
Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects.脂蛋白(a)高脂血症作为心血管危险因素:病理生理学方面。
Clin Res Cardiol Suppl. 2015 Apr;10(Suppl 1):21-5. doi: 10.1007/s11789-015-0074-0.
8
Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.家族性高胆固醇血症中的脂蛋白(a)水平:独立于 LDL 受体突变类型的心血管疾病的重要预测指标。
J Am Coll Cardiol. 2014 May 20;63(19):1982-9. doi: 10.1016/j.jacc.2014.01.063. Epub 2014 Mar 13.
9
Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events.载脂蛋白 B (ApoB) 与 LDL 胆固醇不匹配与未来的冠心病事件相关。
Circulation. 2014 Feb 4;129(5):553-61. doi: 10.1161/CIRCULATIONAHA.113.005873. Epub 2013 Dec 17.
10
Carotid intima-media thickness in children with familial hypercholesterolemia.家族性高胆固醇血症患儿的颈动脉内膜中层厚度。
Circ Res. 2014 Jan 17;114(2):307-10. doi: 10.1161/CIRCRESAHA.114.301430. Epub 2013 Nov 5.